Featured

Yield Growth (BOSS.C) gets consumers to drink mushroom coffee without tricks or tactics

December 6, 2019 by Joseph Morton

Flourish Mushrooms Labs, a subsidiary of Yield Growth (BOSS.C) started consumer tasting trials for four organic mushroom coffee formulations using freshly ground coffee beans and various mushroom formulations today.

Absolem Health signs a mushroom extraction deal

November 27, 2019 by Lukas Kane

On November 26, 2019  Absolem Health announced that it has entered into an L.O.I with Arev Brands (AREV.C) to “develop and produce mushroom extracts”, and potentially to collaborate to sell “mushroom-based products.”

How MAPS broke from the pack of profit-oriented psychedelic industry

November 19, 2019 by Ethan ReyesMAPS, Doblin, COMPASS Pathways, Mental illness, PTSD

With a stated mission of patients over profits, the Multidisciplinary Association for Psychedelic Studies (MAPS) is an outlier within the growing psychedelic treatment industry.


Latest

Yield Growth (BOSS.C) expands their mushroom coffee empire into Europe

November 12, 2019 by Joseph Morton

Yield Growth (BOSS.C) signed a distribution deal with Eurolife Brands to expand their subsidiary, Flourish Mushroom Labs, mushroom-infused coffee concoctions throughout Europe.

Move over JUUL, psilocybin is the key to quitting smoking

October 31, 2019 by Ethan ReyesJUUL, COMPASS PATHWAYS, smoking cessation, depression, clinical trials

Psilocybin, a compound which has shown promise in counteracting treatment-resistant depression, leads the charge in helping JUUL users and smokers alike quit for good, according to a paper from Johns Hopkins University.

MindMed, owners of addiction-treating 18-MC, and Broadway Gold (BRD.V) announce definite arrangement for RTO

October 15, 2019 by Ethan ReyesIbogaine, 18-MC, mindmed, opioid use disorder, treatment, WEED.T, Bruce Linton, Shark Tank

MindMed, owners of the iboga-related 18-MC drug, is going public after firming up its reverse take-over of Broadway Gold Mining (BRD.V).

Yield Growth (BOSS.C) goes all in on #shroomboom with acquisition of recipes for Flourish Mushroom Labs

October 10, 2019 by Ethan ReyesYield Growth, Absolem, Flourish Mushroom Labs, reishi, turkey tail, cordyceps, lion's mane, BOSS.C, cancer

Yield Growth (BOSS.C) has decided not to proceed with the previously announced investment into Absolem Health, instead advancing with their own subsidiary, Flourish Mushroom Labs, which has completed its acquisition of edible mushroom formulas.